Willow Biosciences Inc (WLLW) - Total Assets

Latest as of March 2025: CA$2.31 Million CAD ≈ $1.67 Million USD

Based on the latest financial reports, Willow Biosciences Inc (WLLW) holds total assets worth CA$2.31 Million CAD (≈ $1.67 Million USD) as of March 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check how aggressively does Willow Biosciences Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Willow Biosciences Inc - Total Assets Trend (2000–2024)

This chart illustrates how Willow Biosciences Inc's total assets have evolved over time, based on quarterly financial data. Explore Willow Biosciences Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Willow Biosciences Inc - Asset Composition Analysis

Current Asset Composition (December 2024)

Willow Biosciences Inc's total assets of CA$2.31 Million consist of 26.4% current assets and 73.6% non-current assets.

Asset Category	Amount (CAD)	% of Total Assets
Cash & Equivalents	CA$0.00	13.4%
Accounts Receivable	CA$39.00K	1.6%
Inventory	CA$56.00K	2.3%
Property, Plant & Equipment	CA$0.00	0.0%
Intangible Assets	CA$0.00	0.0%
Goodwill	CA$0.00	0.0%

Asset Composition Trend (2000–2024)

This chart illustrates how Willow Biosciences Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see WLLW market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Willow Biosciences Inc's current assets represent 26.4% of total assets in 2024, a decrease from 100.0% in 2000.
Cash Position: Cash and equivalents constituted 13.4% of total assets in 2024, up from 0.1% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
Asset Diversification: The largest asset category is inventory at 2.3% of total assets.

Willow Biosciences Inc Competitors by Total Assets

Key competitors of Willow Biosciences Inc based on total assets are shown below.

Company	Country	Total Assets
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Sweden	Skr81.26 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs585.02 Billion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Tianjin Chase Sun Pharmaceutical Co Ltd SHE:300026	China	CN¥10.37 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	China	CN¥7.28 Billion
Xeris Pharmaceuticals Inc NASDAQ:XERS	USA	$392.01 Million
Procter & Gamble Health Limited NSE:PGHL	India	Rs8.94 Billion

Willow Biosciences Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.01	1.42	9.12
Quick Ratio	1.01	1.29	8.97
Cash Ratio	0.00	0.00	0.00
Working Capital	CA$17.00K	CA$702.00K	CA$12.22 Million

Willow Biosciences Inc - Advanced Valuation Insights

This section examines the relationship between Willow Biosciences Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	9.89
Latest Market Cap to Assets Ratio	2.07
Asset Growth Rate (YoY)	-62.7%
Total Assets	CA$2.49 Million
Market Capitalization	$5.15 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Willow Biosciences Inc's assets at a significant premium (2.07x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Willow Biosciences Inc's assets decreased by 62.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Willow Biosciences Inc (2000–2024)

The table below shows the annual total assets of Willow Biosciences Inc from 2000 to 2024.

Year	Total Assets	Change
2024-12-31	CA$2.49 Million ≈ $1.80 Million	-62.70%
2023-12-31	CA$6.67 Million ≈ $4.83 Million	-63.23%
2022-12-31	CA$18.15 Million ≈ $13.13 Million	-48.17%
2021-12-31	CA$35.02 Million ≈ $25.33 Million	+60.15%
2020-12-31	CA$21.86 Million ≈ $15.82 Million	-35.47%
2019-12-31	CA$33.88 Million ≈ $24.51 Million	+3403.87%
2018-12-31	CA$967.03K ≈ $699.54K	+33.53%
2017-12-31	CA$724.18K ≈ $523.86K	-57.39%
2016-12-31	CA$1.70 Million ≈ $1.23 Million	-29.64%
2015-12-31	CA$2.42 Million ≈ $1.75 Million	-0.55%
2014-12-31	CA$2.43 Million ≈ $1.76 Million	+1.79%
2013-12-31	CA$2.39 Million ≈ $1.73 Million	+11.65%
2012-12-31	CA$2.14 Million ≈ $1.55 Million	-29.74%
2011-12-31	CA$3.04 Million ≈ $2.20 Million	-18.37%
2010-12-31	CA$3.73 Million ≈ $2.70 Million	-33.03%
2009-12-31	CA$5.56 Million ≈ $4.02 Million	+27.20%
2008-12-31	CA$4.37 Million ≈ $3.16 Million	+42.36%
2007-12-31	CA$3.07 Million ≈ $2.22 Million	+394.02%
2006-12-31	CA$621.91K ≈ $449.88K	+31.68%
2005-12-31	CA$472.29K ≈ $341.65K	+44455.66%
2004-12-31	CA$1.06K ≈ $766.79	-98.90%
2002-12-31	CA$96.40K ≈ $69.74K	-2.90%
2001-12-31	CA$99.28K ≈ $71.81K	-9.61%
2000-12-31	CA$109.83K ≈ $79.45K	--

About Willow Biosciences Inc

TO:WLLW Canada Drug Manufacturers - Specialty & Generic

Market Cap

$18.10 Million

CA$25.02 Million CAD

Market Cap Rank

#28516 Global

#1280 in Canada

Share Price

CA$0.17

Change (1 day)

+0.00%

52-Week Range

CA$0.03 - CA$0.32

All Time High

CA$2.08